LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?
- 28 February 2006
- journal article
- review article
- Published by Elsevier BV in Trends in Molecular Medicine
- Vol. 12 (2), 76-82
- https://doi.org/10.1016/j.molmed.2005.12.004
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Dopamine covalently modifies and functionally inactivates parkinNature Medicine, 2005
- Tau Suppression in a Neurodegenerative Mouse Model Improves Memory FunctionScience, 2005
- Double-knockout mice for α- and β-synucleins: Effect on synaptic functionsProceedings of the National Academy of Sciences of the United States of America, 2004
- α-synuclein locus duplication as a cause of familial Parkinson's diseaseThe Lancet, 2004
- Parkin genetics: one model for Parkinson's diseaseHuman Molecular Genetics, 2004
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003
- α-Synuclein Locus Triplication Causes Parkinson's DiseaseScience, 2003
- Functional analysis of intra-allelic variation at NACP-Rep1 in the ?-synuclein geneHuman Genetics, 2003
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997